Showing results (1-10 of 287) with videos related to
Sort By:
Pageof 29
Antiviral Therapy|July 1, 2010
Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapyRobert Dennert, Sebastiaan Velthuis, Dirk Westermann, et al.Antiviral Chemistry & Chemotherapy|February 2, 2012
Virus infection of the heart--unmet therapeutic needsMark Hazebroek, Robert Dennert, Stephane HeymansEuropean Heart Journal|July 12, 2008
Acute viral myocarditisRobert Dennert, Harry J Crijns, Stephane HeymansAntiviral Therapy|April 14, 2010
Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral loadRobert Dennert, Sebastiaan Velthuis, Simon Schalla, et al.European Journal of Heart Failure|October 18, 2016
Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literatureJob Verdonschot, Mark Hazebroek, Jort Merken, et al.Journal of Molecular and Cellular Cardiology|October 6, 2009
TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'Davy Vanhoutte, Stephane HeymansCardiovascular Research|October 14, 2011
Small but smart--microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageingBlanche Schroen, Stephane HeymansCirculation. Cardiovascular Genetics|October 6, 2010
Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular diseaseMaarten F Corsten, Robert Dennert, Sylvia Jochems, et al.Immunobiology|September 13, 2011
Interactions between the extracellular matrix and inflammation during viral myocarditisAnna-Pia Papageorgiou, Stephane HeymansHypertension (Dallas, Tex. : 1979)|September 19, 2012
MicroRNAs are involved in end-organ damage during hypertensionWard A Heggermont, Stephane HeymansPageof 29